Drug Approvals
Whoa Baby! Here's How I'm Trading Johnson & Johnson After Earnings
The revenue and earnings beats are nice but that's not what really got me fired up.
Could Johnson & Johnson Go Higher and Higher?
Will the vaccine will be a game changer? The charts are giving indications that J&J is ready to run.
High Flying TG Therapeutics Needs a Period of Consolidation
Let's review the charts and indicators.
Market Themes, Yield Spreads, Treasury Auction, JNJ Vaccine, Trading Medtronic
If all goes well, JNJ could be able to immunize a billion individuals this year just by themselves.
Jim Cramer: Looking for Gold? Go With Science
A potential breakthrough in Alzheimer's. A new device for blood pressure. More vaccines. These are opportunities to cheer in a time of turmoil.
Here's Why Eli Lilly Broke to the Upside
Let's review the charts and indicators.
The Correction in AstraZeneca Could Be Nearing an End
Aggressive traders might want to look past any near-term price weakness and consider a small long position.
Assessing AstraZeneca in the Fight Against the Virus
While there are certainly some things to like about AZN, I don't think this vaccine, nor the UK emergency authorization, make it investable.
Here Are 2 'Stocking Stuffers' for Covered Call Aficionados
I added to my stake in UniQure and initiated a new position in Lexicon Pharmaceuticals.
Markets This Week, Cyber-Espionage, Stimulus at Hand, 'New' Covid Strain
Are traders working this holiday shortened week? You bet they are.